Patents by Inventor Min-Jung Park

Min-Jung Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250066965
    Abstract: The present invention relates to a polyester nonwoven fabric with suppressed reduction in physical properties by a tufting process, a method for manufacturing same, and a backing fabric for a carpet, comprising same and, in particular, to: a polyester nonwoven fabric in which, by controlling the physical properties of fibers of a first component filament and a second filament, a reduction in physical properties is remarkably suppressed before/after a tufting process, thus enabling the manufacture of a carpet backing fabric with excellent mechanical properties; a method for manufacturing same; and a backing fabric for a carpet, manufactured thereby.
    Type: Application
    Filed: December 20, 2022
    Publication date: February 27, 2025
    Inventors: Dongheon KANG, Min-ho LEE, Hee-jung CHO, Young-shin PARK, Woo-seok CHOI, Jung-soon JANG
  • Publication number: 20250066347
    Abstract: The present invention relates to: a substituted thiazolidinedione derivative compound having a novel structure acting as a sterol regulatory element-binding protein-1 (SREBP1) inhibitor, a hydrate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating cancer, comprising same as an active ingredient.
    Type: Application
    Filed: December 19, 2022
    Publication date: February 27, 2025
    Inventors: Jun-Kyum KIM, Jia CHOI, Eun-Jung KIM, Cheol-Kyu PARK, Seok Won HAM, Min Gi PARK, Hyeon Ju JEONG, Sung Jin KIM, Kyungim MIN, Jong Min PARK, Jungwook CHIN, Sung Jin CHO, Jina KIM, Kyung Jin JUNG, Nayeon KIM, Suhui KIM, Sugyeong KWON, Su-Jeong LEE, Minseon JEONG, Hongchan AN, Jeong-Eun PARK, Dong-Hyun KIM, Ji-youn LIM, Ju-sik MIN, Ji Sun HWANG, Hyo-Jung CHOI, Hayoung HWANG, Oh-Bin KWON, Sungwoo LEE, Sang Bum KIM
  • Patent number: 12233099
    Abstract: The present invention relates to a composition for promoting myogenesis, containing, as an active ingredient, a processed ginseng extract in which a trace amount of a ginsenoside ingredient is increased. It has been ascertained that the processed ginseng extract promotes the differentiation of myoblasts into muscle and inhibits muscle atrophy caused by myostatin, which is a myogenesis inhibitory factor, and thus it is expected that a composition for preventing or treating muscle disorder-related diseases, having excellent effects, can be developed.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: February 25, 2025
    Assignee: GREEN CROSS WELLBEING CORPORATION
    Inventors: Sun Kyu Park, Jeom Yong Kim, Young Hyo Yoo, Min Jung Jang, Chang Taek Oh, Min Ju Lim, Gwan Su Yi, Yi Li, Yoon Hyeok Lee, Jae Cheal Yoo
  • Patent number: 12235581
    Abstract: The inventive concept provides a method for treating a substrate. In the substrate treating method, a liquid film is formed by supplying a treatment liquid to the rotating substrate, and a wetting medium is sprayed in a form of fine particles to the substrate to help diffusion of the liquid film.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: February 25, 2025
    Assignee: SEMES CO., LTD.
    Inventors: Min Jung Park, Jung Yul Lee
  • Publication number: 20250026835
    Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmunre diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.
    Type: Application
    Filed: July 3, 2024
    Publication date: January 23, 2025
    Applicant: HANALL BIOPHARMA CO., LTD.
    Inventors: Sung Wuk KIM, Seung Kook PARK, Jae Kap JEONG, Hyea Kyung AHN, Min Sun KIM, Eun Sun KIM, Hae-Young YONG, Dongok SHIN, Yeon Jung SONG, Tae Hyoung YOO
  • Publication number: 20250026002
    Abstract: A muscular strength assisting apparatus includes a muscular strength assisting portion that assists a user's muscular strength and a first connecting link including one side connected to one side of the muscular strength assisting portion and an opposite side rotatable relative to a shoulder of the user about a first rotation axis. The muscular strength assisting portion includes an upper arm module that assists muscular strength of an upper arm of the user and a link assembly including one side connected to one side of the upper arm module to be rotatable about a second rotation axis non-parallel to the first rotation axis and an opposite side disposed adjacent to a portion of a body of the user to be supported on the user.
    Type: Application
    Filed: June 5, 2024
    Publication date: January 23, 2025
    Applicants: Hyundai Motor Company, Kia Corporation
    Inventors: Kyu Jung KIM, Sung Woo Park, Hyun Seop Lim, Ju Young Yoon, Beom Su Kim, Min Woong Jeung, Seong Taek Hwang, Hyeon Jeong An, Ho Jun Kim, Moon Ki Jung, Soo Kyung Kang, Dong Jin Hyun, Hyo Joong Kim
  • Publication number: 20250009817
    Abstract: Provided is an immunomodulatory treatment composition for a transplantation disease through combined administration of a microbiome and an immunosuppressant. According to the present disclosure, it was confirmed that in an allogeneic transplantation cell model, combined administration of FK506 and the microbiome suppressed alloresponse and regulated the activity of T cells and B cells. Further, it was confirmed that in an acute graft-versus-host disease animal model, the combined administration reduced the disease activity, increased the probability of survival, and protected the tissue damage. In addition, it was confirmed that the combined administration improved transplantation rejection diseases by reducing the activity of Th1 and Th17 and increasing the activity of Tregs, and thus can be usefully used as an immunomodulator for transplantation rejection.
    Type: Application
    Filed: January 19, 2024
    Publication date: January 9, 2025
    Applicant: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Mi-La CHO, Min-Jung PARK, Joo-Yeon JHUN, Seung-Yoon LEE, Se-Gyeong HAN
  • Patent number: 12181391
    Abstract: The present invention relates to a sample diluting and dispensing device. The sample diluting and dispensing device according to the present invention includes: a sample holding plate in which a holding part for holding a plurality of sample vessels is formed; a moving unit for transferring the sample holding plate in a plane direction and a height direction; a sample supply unit for supplying a sample to the sample vessel; a diluent supply unit for supplying a diluent to the sample vessel; a scale installed below the sample holding plate to measure a weight of the sample vessel; and a controller for receiving a weight measurement result from the scale and controlling an operation of each of the sample holding plate, the sample supply unit, and the diluent supply unit.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: December 31, 2024
    Assignee: KOREA INSTITUTE OF GEOSCIENCE AND MINERAL RESOURCES (KIGAM)
    Inventors: Jung Hun Park, Gyujun Park, Min Jung Park
  • Publication number: 20240309336
    Abstract: The present application relates to a method for producing a reassortant Reoviridae virus and a vector library for the same, and provides: a method for producing a reassortant Reoviridae virus by using a cell line into which an RNA polymerase is introduced and an expression vector library according to an aspect; a reassortant Reoviridae virus produced by the method; and an expression vector library for producing reassortant rotavirus.
    Type: Application
    Filed: June 24, 2022
    Publication date: September 19, 2024
    Inventors: Ki Weon SEO, Tae Woo KWON, Seo Yeon JUNG, Min Jung PARK, Kun Se LEE, Hyun Joo LEE
  • Publication number: 20240219838
    Abstract: The inventive concept provides a substrate treating method. The substrate treating apparatus includes supplying a first liquid to a rotating substrate to treat a substrate; and supplying a second liquid which is different from the first liquid to the rotating substrate to coat the substrate with the second liquid, and wherein a rotation direction of the substrate is different at the supplying the first liquid and at the supplying the second liquid.
    Type: Application
    Filed: June 27, 2023
    Publication date: July 4, 2024
    Applicant: SEMES CO., LTD.
    Inventors: Soo Bin YONG, Min Jung PARK
  • Patent number: 12017234
    Abstract: A nozzle apparatus may comprise a nozzle body having a nozzle tip with a discharge port for spraying a treatment fluid onto a substrate; a nozzle moving member for moving the nozzle body relative to the substrate; a rotating member for rotating the nozzle body or the nozzle tip so that a treatment fluid is sprayed onto the substrate during rotation; and a control unit configured to control an operation of the nozzle moving member and the rotating member.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: June 25, 2024
    Assignee: SEMES CO., LTD.
    Inventor: Min Jung Park
  • Publication number: 20240192602
    Abstract: The inventive concept provides a substrate treating method. The substrate treating apparatus includes first treating including supplying a first liquid to a rotating substrate; and second treating including supplying a second liquid to the rotating substrate after the supplying of the first liquid, and wherein a rotation speed of a substrate is changed during the supplying of the first liquid to the rotating substrate.
    Type: Application
    Filed: June 12, 2023
    Publication date: June 13, 2024
    Applicant: SEMES CO., LTD.
    Inventors: Min Jung PARK, Soo Bin YONG, Jae Hoon PARK
  • Publication number: 20240139331
    Abstract: The present invention relates to a pharmaceutical composition, for treating glioblastoma, comprising a nucleic acid complex as an active ingredient and, more particularly, to a pharmaceutical composition, for preventing or treating glioblastoma, comprising a nucleic acid complex having complementarily bound: a bioactive peptide nucleic acid having a sequence binding to TGF-?2 gene; and a carrier peptide nucleic acid. The nucleic acid complex according to the present invention has excellent cell permeability and intracellular activity and can effectively inhibit the expression of TGF-?2 gene and the hypostatic gene thereof, and thus is useful in preventing or treating glioblastoma.
    Type: Application
    Filed: December 14, 2021
    Publication date: May 2, 2024
    Inventors: Min-Jung PARK, Hye Joo KIM, Ji-Yeon YU, Hee Kyung PARK
  • Patent number: 11969397
    Abstract: The present invention relates to a composition for preventing or treating transplantation rejection or a transplantation rejection disease, comprising a novel compound and a calcineurin inhibitor. A co-administration of the present invention 1) reduces the activity of pathogenic Th1 cells or Th17 cells, 2) increases the activity of Treg cells, 3) has an inhibitory effect against side effects, such as tissue damage, occurring in the sole administration thereof, 4) inhibits various pathogenic pathways, 5) inhibits the cell death of inflammatory cells, and 6) increases the activity of mitochondria, in an in vivo or in vitro allogenic model, a transplantation rejection disease model, a skin transplantation model, and a liver-transplanted patient, and thus inhibits transplantation rejection along with mitigating side effects possibly occurring in the administration of a conventional immunosuppressant alone.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: April 30, 2024
    Assignee: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Mi-La Cho, Dong-Yun Shin, Jong-Young Choi, Chul-Woo Yang, Sung-Hwan Park, Seon-Yeong Lee, Min-Jung Park, Joo-Yeon Jhun, Se-Young Kim, Hyeon-Beom Seo, Jae-Yoon Ryu, Keun-Hyung Cho
  • Publication number: 20240076663
    Abstract: The present invention relates to a novel-structured nucleic acid complex having a blood-brain barrier penetration ability and a composition comprising same and, more specifically, to a nucleic acid complex in which a bioactive nucleic acid is complementarily bound to a carrier peptide nucleic acid modified to be generally positively charged, and to a composition for blood-brain barrier penetration comprising same. The nucleic acid complex according to the present invention can penetrate the blood-brain barrier at excellent efficiency, and especially, the conjugation of a drug into the nucleic acid complex increases the blood-brain barrier penetration ability of the drug, and thus is very useful in treatment or diagnosis of diseases.
    Type: Application
    Filed: October 15, 2020
    Publication date: March 7, 2024
    Inventors: Min-Jung PARK, Hye Joo KIM, Ji-Yeon YU, Hee Kyung PARK
  • Patent number: 11885768
    Abstract: The present invention relates to a semi-automatic scanner for ultrasonic inspection of a branch pipe weld that has a small size and is able to perform an inspection while moving in a state of being attached to a test object by a magnetic force, thereby being applied to fittings having various shapes, such as a branch pipe and an elbow.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: January 30, 2024
    Assignees: Korea Inspection Eng. Co., Ltd, Foundation for Research and Business, Seoul National University of Science and Technology
    Inventors: Seong Jin Lim, In Gon Jung, Min Jung Park, Ik Keun Park, Tae Sung Park
  • Publication number: 20230346963
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating dementia, containing a nucleic acid complex in which a carrier peptide nucleic acid and a bioactive peptide nucleic acid having a sequence for binding to a NLRP3 gene are complementarily bound. The nucleic acid complex according to the present invention has a blood-brain barrier penetration ability and can effectively inhibit expression and phosphorylation of the protein of the NLRP3 gene and tau, which a lower-level gene, and thus is useful in the prevention or treatment of dementia.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 2, 2023
    Inventors: Min-Jung PARK, Hye Joo KIM, Ji-Yeon YU, Hee Kyung PARK
  • Publication number: 20230288811
    Abstract: The inventive concept provides an apparatus and method for treating a substrate with a gas. The apparatus includes a chamber having a process space in which the substrate is treated, a substrate support unit that supports the substrate in the process space, a gas supply unit that supplies a hydrophobic gas onto the substrate supported on the substrate support unit, and a controller that controls the substrate support unit and the gas supply unit. The substrate support unit includes a support plate on which the substrate is placed and a pin assembly that raises the substrate off the support plate or lowers the substrate onto the support plate, and the controller controls a degree of hydrophobization of a surface of the substrate by adjusting the pin assembly.
    Type: Application
    Filed: May 2, 2023
    Publication date: September 14, 2023
    Applicant: SEMES CO, LTD.
    Inventors: Moon Hyung BAE, Hye Bin BAEK, Youngseo AN, Euntark LEE, Min Jung PARK, Seunghan LEE, Jung-Hyun LEE
  • Patent number: 11628206
    Abstract: The present disclosure relates to a method for inhibiting a STAT3 activity comprising administering SSu72 protein.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: April 18, 2023
    Assignee: CUROGEN TECHNOLOGY CO., LTD.
    Inventors: Mi-La Cho, Sung-Hwan Park, Seung-Ki Kwok, Jong-Young Choi, Seung-Hun Lee, Hyeon-Beom Seo, Young-Mee Moon, Jin-Sil Park, Min-Jung Park, Jin-Kwan Lee, Chang Woo Lee
  • Patent number: 11557477
    Abstract: An apparatus for treating a substrate includes a heat treatment chamber having an interior space, a housing that is provided in the interior space and that has a treatment space therein, a gas supply line that supplies, into the treatment space, a hydrophobic gas for hydrophobicizing the substrate, and a decomposition unit that decomposes an alkaline gas leaking from the treatment space to the interior space.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: January 17, 2023
    Assignee: Semes Co., Ltd.
    Inventors: Min Jung Park, Kyungjin Seo, Younghun Jung